Given ATP’s role as a ubiquitous energy source, it is challenging to selectively modulate eATP levels to sustain P2X7R/NLRP3 signaling and enhance chemotherapy-induced immunogenicity in the tumor microenvironment (TME). This evidence concerns the gene NLRP3 and neoplasm.